Ilyang Pharm (007570) — Free Cash Flow Generation Index
Ilyang Pharm (007570) has a Free Cash Flow Generation Index of -0.47x as of June 2025. Free cash flow of ₩-1.06 Billion represents 0% of operating cash flow (₩2.26 Billion). See 007570 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Ilyang Pharm Free Cash Flow Generation Index (2003–2024)
Historical FCF Generation Index trend for Ilyang Pharm across 12 annual periods. Explore Ilyang Pharm (007570) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Ilyang Pharm (2003–2024)
Year-by-year Free Cash Flow Generation Index for Ilyang Pharm. For the full company profile including market capitalisation, see how much is Ilyang Pharm worth.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.23x | ₩-35.01 Billion | ₩5.61 Billion | ₩40.62 Billion | ▼ -1311.0% |
| 2023 | 0.51x | ₩6.87 Billion | ₩13.34 Billion | ₩6.47 Billion | ▲ +64.0% |
| 2022 | 0.31x | ₩9.40 Billion | ₩29.94 Billion | ₩4.08 Billion | ▼ -53.9% |
| 2021 | 0.68x | ₩45.67 Billion | ₩67.02 Billion | ₩12.91 Billion | ▲ +19.2% |
| 2020 | 0.57x | ₩32.86 Billion | ₩57.48 Billion | ₩10.17 Billion | ▼ -25.6% |
| 2019 | 0.77x | ₩27.81 Billion | ₩36.19 Billion | ₩2.17 Billion | ▲ +36.6% |
| 2018 | 0.56x | ₩12.44 Billion | ₩22.12 Billion | ₩1.55 Billion | ▼ -19.2% |
| 2017 | 0.70x | ₩20.91 Billion | ₩30.03 Billion | ₩3.78 Billion | ▼ -49.6% |
| 2016 | 1.38x | ₩37.29 Billion | ₩26.98 Billion | ₩10.31 Billion | ▼ -1.2% |
| 2015 | 1.40x | ₩56.35 Billion | ₩40.27 Billion | ₩16.07 Billion | ▼ -19.8% |
| 2014 | 1.75x | ₩32.51 Billion | ₩18.63 Billion | ₩13.89 Billion | ▲ +67.6% |
| 2003 | 1.04x | ₩10.50 Billion | ₩10.08 Billion | ₩415.11 Million | — |